AMDA urges safe, thoughtful approach in new reopening guidance
By
Alicia Lasek
Mar 02, 2021
A return to ‘normal,’ will not be immediate, says Executive Director Christopher Laxton in announcing new, proposed visitation guidelines.
Slow recovery from illness may reflect pandemic-related stress: study
By
Alicia Lasek
Dec 07, 2022
The pandemic itself, including related stress, may be contributing to slow recoveries after COVID and non-COVID illnesses alike, investigators say.
No lasting lung damage found in surgical study of recovered COVID-19 patients
By
Alicia Lasek
Aug 16, 2021
Tissue sample analysis from recovered COVID-19 patients who had unrelated lung surgeries showed that the telltale signs of COVID-19 lung damage were undetectable at three months.
COVID-19 nursing home deaths drop; booster skepticism a concern, industry experts say
By
Alicia Lasek
Apr 05, 2022
Resident deaths have dropped from a January peak, hitting what appears to be the lowest level since the summer of 2021. But experts fear that a lack of urgency could leave some facilities unprepared for...
CDC: Deaths from antibiotic-resistant bacteria jumped 15% in 2020
By
Alicia Lasek (f3)
Jul 13, 2022
The COVID-19 pandemic has “pushed back years of progress” in combating antimicrobial resistance in the United States, the CDC reports.
Feds mull swift sanction of 2nd coronavirus booster
By
Alicia Lasek
Mar 25, 2022
The Biden administration may authorize a second booster shot within weeks, a new report finds. Officials want to get ahead of an expected uptick in SARS-CoV-2 infections, sources say.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
Risk of COVID-19 death rare in vaccinated, even among at-risk seniors with comorbidities: study
By
Alicia Lasek
Jan 10, 2022
Investigators drew on data from 1.2 million U.S. patients who completed a primary vaccination series by October 2021. Severe COVID-19 outcomes, including respiratory failure, ICU admission, or death, were...
Post-COVID complaints continue to affect recovered healthcare workers, study finds
By
Alicia Lasek (f3)
Jul 21, 2022
Pulmonary tests may be useful in the decision to return to work, and should be received regularly after workers with lingering issues are back on the job, investigators say.